Oleg Grodnensky

Chief Financial Officer, AEON Biopharma, Inc.

Companies

Priveterra Acquisition Corp. IIBoard member Jul 13, 2023 to Jul 13, 2023¹
Priveterra Acquisition Corp. IIChief executive officer Jul 13, 2023 to Jul 13, 2023¹
AEON Biopharma, Inc.Board member Feb 8, 2021 to Feb 8, 2021²
AEON Biopharma, Inc.Chief financial officer Feb 8, 2021 to Feb 8, 2021²
AEON Biopharma, Inc.Chief operating officer Feb 8, 2021 to Feb 8, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

AEON Biopharma, Inc. AEON13,889,163 shares³$3.3M at $0.24Jul 21, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 21, 2023Converted 89,163 shares of AEON Biopharma, Inc.³
Jul 21, 2023Converted 6,900,000 shares of AEON Biopharma, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPriveterra Acquisition Corp. II, Board member
2
SEC EDGARAEON Biopharma, Inc., Board member
3
SEC EDGARAEON Biopharma, Inc. shares after the filing of Jul 21, 2023